As a diverse and inclusive team, Koneksa challenges traditional development paradigms to work at the intersection of what some would consider competing forces—compliance and innovation. We believe new science, technology, analytics, and agile learning are core drivers in developing patient-centric solutions in clinical trials.
Our work with digital biomarkers is an essential piece of clinical research. We help our customers use technology to make informed investment decisions and regulatory claims about life-altering new medicines. Koneksa’s success in this highly regulated environment demands attention to detail and a commitment to compliance. Yet our unique approach to deliver results with agility and flexibility is what best serves our sponsors, sites, and patients.